Insider Trading activities of Amylin Pharmaceuticals Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amylin Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Amylin Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Amylin Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is AMLN. The reporting company's CIK number is 881464.
The total value of stock buying since 2005 is $166,931,228.
The total value of stock sales since 2005 is $345,994,933.
The total value of stock option exercises since 2005 is $11,112,250.


Go to page:  1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Amylin Pharmaceuticals Inc insiders (AMLN) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2007-10-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Sale 2,000 49.67 99,340
2007-10-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Option Ex 2,000 16.54 33,080
2007-10-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 49.77 333,438
2007-10-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 6,700 10.38 69,512
2007-10-01 Eberhard Craig A (VP Sales) Sale 1,000 49.67 49,670
2007-10-01 Eberhard Craig A (VP Sales) Option Ex 1,000 18.85 18,850
2007-10-01 Baron Alain D (Sr VP Research) Sale 3,000 49.81 149,436
2007-10-01 Baron Alain D (Sr VP Research) Option Ex 3,000 7.19 21,561
2007-10-01 Greene Howard E Jr (Director) Sale 3,700 49.54 183,283
2007-09-28 Foletta Mark G (Senior VP, Finance & CFO) Sale 3,000 49.98 149,931
2007-09-28 Foletta Mark G (Senior VP, Finance & CFO) Option Ex 3,000 13.25 39,750
2007-09-26 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 50.00 250,000
2007-09-26 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,000 5.73 28,650
2007-09-18 Baron Alain D (Sr VP Research) Sale 1,000 47.75 47,750
2007-09-18 Baron Alain D (Sr VP Research) Option Ex 1,000 7.19 7,187
2007-09-18 Cook Joseph C Jr (Director) Sale 10,000 47.56 475,590
2007-09-17 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 48.74 243,710
2007-09-17 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,000 5.73 28,650
2007-09-17 Greene Howard E Jr (Director) Sale 3,700 47.88 177,144
2007-09-05 Graham Ginger L (Executive Advisor) Option Ex 1,450 19.77 28,666
2007-09-04 Gergen Mark J (Sr VP, Corporate Development) Sale 1,000 49.50 49,500
2007-09-04 Gergen Mark J (Sr VP, Corporate Development) Option Ex 1,000 16.80 16,800
2007-09-04 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Sale 2,000 48.99 97,988
2007-09-04 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Option Ex 2,000 20.72 41,450
2007-09-04 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 48.97 328,112
2007-09-04 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 6,700 9.62 64,487
2007-09-04 Eberhard Craig A (VP Sales) Sale 1,000 48.99 48,994
2007-09-04 Eberhard Craig A (VP Sales) Option Ex 1,000 18.85 18,850
2007-09-04 Baron Alain D (Sr VP Research) Sale 4,000 49.50 198,000
2007-09-04 Baron Alain D (Sr VP Research) Option Ex 4,000 7.19 28,748
2007-09-04 Cook Joseph C Jr (Director) Sale 10,000 49.49 494,910
2007-09-04 Greene Howard E Jr (Director) Sale 3,700 49.50 183,157
2007-08-31 Foletta Mark G (Senior VP, Finance & CFO) Sale 3,000 48.86 146,574
2007-08-31 Foletta Mark G (Senior VP, Finance & CFO) Option Ex 3,000 13.25 39,750
2007-08-20 Baron Alain D (Sr VP Research) Sale 1,000 49.00 49,000
2007-08-20 Baron Alain D (Sr VP Research) Option Ex 1,000 11.12 11,125
2007-08-20 Greene Howard E Jr (Director) Sale 3,700 48.92 180,992
2007-08-17 Cook Joseph C Jr (Director) Sale 100 47.65 4,765
2007-08-16 Cook Joseph C Jr (Director) Sale 9,900 48.26 477,803
2007-08-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 10,000 49.10 491,000
2007-08-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 10,000 14.28 142,810
2007-08-08 Baron Alain D (Sr VP Research) Sale 1,000 53.00 53,000
2007-08-08 Baron Alain D (Sr VP Research) Option Ex 1,000 7.19 7,187
2007-08-08 Wilson James N (Director) Sale 3,334 51.44 171,514
2007-08-08 Graham Ginger L (Executive Advisor) Sale 23,000 51.33 1,180,659
2007-08-08 Graham Ginger L (Executive Advisor) Option Ex 23,000 13.14 302,289
2007-08-07 Gergen Mark J (Sr VP, Corporate Development) Sale 500 50.00 25,000
2007-08-07 Gergen Mark J (Sr VP, Corporate Development) Option Ex 500 16.80 8,400
2007-08-07 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 50.00 250,000
2007-08-07 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,000 14.28 71,405
2007-08-07 Baron Alain D (Sr VP Research) Sale 1,000 50.00 50,000
2007-08-07 Baron Alain D (Sr VP Research) Option Ex 1,000 7.19 7,187
2007-08-07 Wilson James N (Director) Sale 5,334 50.10 267,260
2007-08-07 Graham Ginger L (Executive Advisor) Sale 10,000 50.51 505,100
2007-08-07 Graham Ginger L (Executive Advisor) Option Ex 10,000 10.25 102,500
2007-08-06 Graham Ginger L (Executive Advisor) Sale 10,000 49.50 495,010
2007-08-06 Graham Ginger L (Executive Advisor) Option Ex 10,000 4.38 43,750
2007-08-06 Greene Howard E Jr (Director) Sale 3,846 48.67 187,188
2007-08-02 Cook Joseph C Jr (Director) Sale 100 46.63 4,663
2007-08-01 Gergen Mark J (Sr VP, Corporate Development) Sale 500 46.50 23,250
2007-08-01 Gergen Mark J (Sr VP, Corporate Development) Option Ex 500 16.80 8,400
2007-08-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Sale 2,000 46.31 92,622
2007-08-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Option Ex 2,000 18.85 37,700
2007-08-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 1,700 46.50 79,050
2007-08-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 1,700 9.62 16,362
2007-08-01 Eberhard Craig A (VP Sales) Sale 2,000 46.31 92,622
2007-08-01 Eberhard Craig A (VP Sales) Option Ex 2,000 18.85 37,700
2007-08-01 Baron Alain D (Sr VP Research) Sale 3,000 46.50 139,500
2007-08-01 Baron Alain D (Sr VP Research) Option Ex 3,000 7.19 21,561
2007-08-01 Cook Joseph C Jr (Director) Sale 9,900 46.54 460,726
2007-07-31 Foletta Mark G (Senior VP, Finance & CFO) Sale 3,500 47.43 166,019
2007-07-31 Foletta Mark G (Senior VP, Finance & CFO) Option Ex 3,500 13.25 46,375
2007-07-27 Cook Joseph C Jr (Director) Option Ex 140,000 2.66 371,840
2007-07-24 Gergen Mark J (Sr VP, Corporate Development) Sale 500 45.00 22,500
2007-07-24 Gergen Mark J (Sr VP, Corporate Development) Option Ex 500 16.80 8,400
2007-07-24 Baron Alain D (Sr VP Research) Sale 2,000 45.50 91,000
2007-07-24 Baron Alain D (Sr VP Research) Option Ex 2,000 9.57 19,136
2007-07-23 Greene Howard E Jr (Director) Sale 3,846 43.34 166,697
2007-07-18 Baron Alain D (Sr VP Research) Sale 1,000 43.18 43,180
2007-07-18 Baron Alain D (Sr VP Research) Option Ex 1,000 11.95 11,950
2007-07-17 Cook Joseph C Jr (Director) Sale 10,000 42.96 429,610
2007-07-16 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 43.69 292,702
2007-07-16 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 6,700 8.42 56,387
2007-07-12 Baron Alain D (Sr VP Research) Sale 2,000 43.00 86,000
2007-07-12 Baron Alain D (Sr VP Research) Option Ex 2,000 7.19 14,374
2007-07-09 Greene Howard E Jr (Director) Sale 3,846 42.33 162,801
2007-07-03 Cook Joseph C Jr (Director) Sale 10,000 41.92 419,180
2007-07-02 Gergen Mark J (Sr VP, Corporate Development) Sale 500 41.20 20,600
2007-07-02 Gergen Mark J (Sr VP, Corporate Development) Option Ex 500 16.80 8,400
2007-07-02 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Sale 2,000 41.00 82,000
2007-07-02 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Option Ex 2,000 18.85 37,700
2007-07-02 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 41.16 205,805
2007-07-02 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,000 1.61 8,045
2007-06-29 Foletta Mark G (Senior VP, Finance & CFO) Sale 2,500 41.38 103,455
2007-06-29 Foletta Mark G (Senior VP, Finance & CFO) Option Ex 2,500 13.25 33,125
2007-06-25 Greene Howard E Jr (Director) Sale 3,846 41.34 158,989
2007-06-18 Baron Alain D (Sr VP Research) Sale 1,000 42.97 42,970
2007-06-18 Baron Alain D (Sr VP Research) Option Ex 1,000 9.62 9,625
2007-06-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 42.99 288,026
2007-06-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 6,700 7.81 52,340
2007-06-12 Graham Ginger L (Executive Advisor) Option Ex 2,898 23.00 66,654
2007-06-11 Greene Howard E Jr (Director) Sale 3,846 41.46 159,470
2007-06-04 Cook Joseph C Jr (Director) Sale 10,000 44.76 447,650
2007-06-01 Gergen Mark J (Sr VP, Corporate Development) Sale 1,000 46.16 46,160
2007-06-01 Gergen Mark J (Sr VP, Corporate Development) Option Ex 1,000 16.80 16,800
2007-06-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Sale 2,000 46.64 93,280
2007-06-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Option Ex 2,000 18.85 37,700
2007-06-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 46.12 230,615
2007-06-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,000 .31 1,565
2007-06-01 Eberhard Craig A (VP Sales) Sale 2,000 46.00 91,998
2007-06-01 Eberhard Craig A (VP Sales) Option Ex 2,000 18.85 37,700
2007-06-01 Baron Alain D (Sr VP Research) Sale 4,000 46.16 184,640
2007-06-01 Baron Alain D (Sr VP Research) Option Ex 4,000 9.06 36,252
2007-06-01 Testman Thomas R (Director) Sale 12,000 46.62 559,380
2007-06-01 Testman Thomas R (Director) Option Ex 12,000 16.23 194,760
2007-05-31 Foletta Mark G (Senior VP, Finance & CFO) Sale 6,500 45.79 297,661
2007-05-31 Foletta Mark G (Senior VP, Finance & CFO) Option Ex 6,500 13.25 86,125
2007-05-31 Wilson James N (Director) Sale 2,166 46.24 100,155
2007-05-30 Baron Alain D (Sr VP Research) Sale 1,000 46.00 46,000
2007-05-30 Baron Alain D (Sr VP Research) Option Ex 1,000 11.95 11,950
2007-05-29 Greene Howard E Jr (Director) Sale 3,846 45.20 173,827
2007-05-25 Testman Thomas R (Director) Sale 20,000 44.88 897,600
2007-05-25 Testman Thomas R (Director) Option Ex 20,000 16.99 339,799
2007-05-22 Wilson James N (Director) Sale 500 45.52 22,760
2007-05-21 Gergen Mark J (Sr VP, Corporate Development) Sale 500 45.00 22,500
2007-05-21 Gergen Mark J (Sr VP, Corporate Development) Option Ex 500 16.80 8,400
2007-05-21 Baron Alain D (Sr VP Research) Sale 1,000 45.00 45,000
2007-05-21 Baron Alain D (Sr VP Research) Option Ex 1,000 10.94 10,940
2007-05-21 Wilson James N (Director) Sale 2,166 44.80 97,036
2007-05-17 Cook Joseph C Jr (Director) Sale 10,000 42.52 425,170
2007-05-16 Baron Alain D (Sr VP Research) Sale 1,000 42.29 42,290
2007-05-16 Baron Alain D (Sr VP Research) Option Ex 1,000 7.19 7,187
2007-05-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 42.29 283,329
2007-05-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 6,700 2.03 13,607
2007-05-14 Baron Alain D (Sr VP Research) Sale 2,000 43.00 86,000
2007-05-14 Baron Alain D (Sr VP Research) Option Ex 2,000 11.95 23,900
2007-05-14 Greene Howard E Jr (Director) Sale 3,846 42.90 165,008
2007-05-07 Bradbury Daniel (President & Chief Exec Officer) Sale 2,894 41.90 121,258
2007-05-02 Cook Joseph C Jr (Director) Sale 10,000 42.07 420,700
2007-05-01 Gergen Mark J (Sr VP, Corporate Development) Sale 500 41.25 20,625
2007-05-01 Gergen Mark J (Sr VP, Corporate Development) Option Ex 500 16.80 8,400
2007-05-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Sale 5,000 41.50 207,500
2007-05-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Option Ex 5,000 11.95 59,750
2007-05-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 41.12 205,580
2007-05-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,000 .31 1,565
2007-04-30 Foletta Mark G (Senior VP, Finance & CFO) Sale 2,500 42.32 105,800
2007-04-30 Foletta Mark G (Senior VP, Finance & CFO) Option Ex 2,500 13.25 33,125
2007-04-30 Greene Howard E Jr (Director) Sale 3,846 42.09 161,889
2007-04-27 Baron Alain D (Sr VP Research) Sale 2,000 43.00 86,000
2007-04-27 Baron Alain D (Sr VP Research) Option Ex 2,000 11.95 23,900
Go to page:  1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of AMLN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amylin Pharmaceuticals Inc (symbol AMLN, CIK number 881464) see the Securities and Exchange Commission (SEC) website.